Joseph A. Francisco
- Oncology top 1%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 2%
- Immunology top 10%
- Co-authors
- Dana F. ChacePeter D. SenterDamon L. MeyerCharles G. CervenyClay B. SiegallAlan F. WahlSvetlana O. DoroninaBrian E. Toki
- Topics
- Monoclonal and Polyclonal Antibodies Research (14 papers)HER2/EGFR in Cancer Research (7 papers)Toxin Mechanisms and Immunotoxins (5 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Joseph A. Francisco
16 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Oncology 1.9k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Molecular Biology 1.1k
- Pathology and Forensic Medicine 489
- Immunology 415
Countries citing papers authored by Joseph A. Francisco
This map shows the geographic impact of Joseph A. Francisco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Francisco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Francisco more than expected).
Fields of papers citing papers by Joseph A. Francisco
This network shows the impact of papers produced by Joseph A. Francisco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Francisco. The network helps show where Joseph A. Francisco may publish in the future.
Co-authorship network of co-authors of Joseph A. Francisco
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Francisco. A scholar is included among the top collaborators of Joseph A. Francisco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Francisco. Joseph A. Francisco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 123 | |
| 2 | Immunoconjugates comprised of drugs with impaired cellular permeability: A new approach to targeted therapy | 2 |
| 3 | Effect of drug loading on the pharmacology, pharmacokinetics, and toxicity of an anti-CD30 antibody-drug conjugate | 0 |
| 4 | 84 | |
| 5 | 3 | |
| 6 | Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugatebreakdown → | 909 |
| 7 | Development of potent monoclonal antibody auristatin conjugates for cancer therapybreakdown → | 903 |
| 8 | cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activitybreakdown → | 668 |
| 9 | 11 | |
| 10 | The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease. | 167 |
| 11 | 3 | |
| 12 | 20 | |
| 13 | 41 | |
| 14 | 21 | |
| 15 | Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. | 33 |
| 16 | 32 | |
| 17 | 94 |
About Joseph A. Francisco
Joseph A. Francisco is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology and Allergy, having authored 17 papers that have together received 3.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), HER2/EGFR in Cancer Research (7 papers) and Toxin Mechanisms and Immunotoxins (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.8k citations), Oncology (1.9k citations) and Pathology and Forensic Medicine (489 citations). Joseph A. Francisco has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Dana F. Chace, Peter D. Senter, Damon L. Meyer, Charles G. Cerveny, Clay B. Siegall, Alan F. Wahl, Svetlana O. Doronina, Brian E. Toki, Kevin J. Hamblett and Michael Sun. Their work appears in journals such as Journal of Biological Chemistry, Blood and Nature Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.